In Re Bilski Blog

Bilski Aftermath

What is the future for business method patents? Will Europe's "Technical Effect" test become the law in the U.S.? Robert Hulse examines these issues and analyzes the implications that the Bilski could have on future patent law in a blog post published on PLI's Patent Law Practice Center website.

Webinar on Bilski: Strategies for Prosecuting or Challenging Patent Process Claims Going Forward

Strafford will be offering a webinar entitled "Bilski:  Implications of the Supreme Court's Long-Awaited Ruling:  Strategies for Prosecuting or Challenging Patent Process Claims Going Forward" on August 11, 2010, 2010 from 1:00 - 2:30 PM (EDT).  Erika H. Arner of Finnegan Henderson Farabow Garrett & Dunner; Leigh J. Martinson of McDermott Will & Emery LLP, Boston; and Daniel R. Brownstone of Fenwick & West LLP will provide guidance for counsel and companies concerning the implications of the Supreme Court's recent decision in Bilski v. Kappos, and outline best practices for defending patent applications -- or challenging them --given the continuing lack of clear guidelines for patentability.  The webinar will review the following questions:

• What are the implications of Bilski for patent eligibility?
• What is its anticipated impact for past patent eligibility decisions?
• What strategies should patent applicants employ to improve the likelihood of a successful patent application going forward?
• What are the best practices for challenging patents following the Bilski decision? 

 The registration fee for the webinar is $297 ($362 for registration and CLE processing).  Those registering by July 23, 2010 will receive a $50 discount.  Those interested in registering for the webinar, can do so here.

Strafford will be offering a webinar entitled "Bilski:  Implications of the Supreme Court's Long-Awaited Ruling:  Strategies for Prosecuting or Challenging Patent Process Claims Going Forward" on August 11, 2010, 2010 from 1:00 - 2:30 PM (EDT).  Erika H. Arner of Finnegan Henderson Farabow Garrett & Dunner; Leigh J. Martinson of McDermott Will & Emery LLP, Boston; and Daniel R. Brownstone of Fenwick & West LLP will provide guidance for counsel and companies concerning the implications of the Supreme Court's recent decision in Bilski v. Kappos, and outline best practices for defending patent applications -- or challenging them --given the continuing lack of clear guidelines for patentability.  The webinar will review the following questions:

• What are the implications of Bilski for patent eligibility?
• What is its anticipated impact for past patent eligibility decisions?
• What strategies should patent applicants employ to improve the likelihood of a successful patent application going forward?
• What are the best practices for challenging patents following the Bilski decision? 

 The registration fee for the webinar is $297 ($362 for registration and CLE processing).  Those registering by July 23, 2010 will receive a $50 discount.  Those interested in registering for the webinar, can do so here.

The Buzz about Bilski

Since the Supreme Court's ruling, there has been a flurry of media coverage about Bilski and its implications. Here are two news articles that we found especially interesting:

Top Court Rejects Business Method Patent (Reuters)

Supreme Court issues Mixed Ruling on Method Patents (Wall Street Journal)

Patent Strategy for Personalized Medicine after Bilski

Now that the Supreme Court has invalidated Bilski and Warsaw's business methods patent, many are left wondering how the ruling may affect the personalized medicine industry. The article, Patent Strategy for Personalized Medicine in Light of Bilski, discusses the implications of the Bilski decision on such inventions.

The Court Decides!

On June 28, 2010 the Supreme Court ruled against Bilski and Warsaw's business method patent claims, but left the door open for other inventors to patent their business methods. This Patent Alert analyzes the Supreme Court's decision and discusses the implications for businesses with existing patent portfolios.